Table 3

Base case clinical results: incremental life years per 1,000 patients
Cohort Evaluated Incremental Life Years
PMO Patients (100% Female), age 69 years, T-Score = −3.0
historical vertebral + incident vertebral fracture
 Teriparatide vs. No Treatment 132
 Teriparatide vs. bisphosphonate 102
incident vertebral fracture
 Teriparatide vs. No Treatment 102
 Teriparatide vs. bisphosphonate 77
GIOP Patients (80% Female), age 69 years, T-Score = −2.5
historical vertebral + incident vertebral fracture
 Teriparatide vs. No Treatment 153
 Teriparatide vs. bisphosphonate 117
incident vertebral fracture
 Teriparatide vs. No Treatment 140
 Teriparatide vs. bisphosphonate 106

Murphy et al.

Murphy et al. BMC Musculoskeletal Disorders 2012 13:213   doi:10.1186/1471-2474-13-213

Open Data